In addition to hyperphosphatemia, there are other factors that also contribute to the development and progression of SHPT in the context of CKD: low 1,25OH2D, hypocalcemia, elevated levels of FGF23 and Klotho, and reduced levels of vitamin D receptor11,15,42–44. This evidence concerns the gene FGF23 and Hypocalcemia.